Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters

Journal of Alzheimer's Disease

Volumn 48, Issue 3, 2015, Pages 833-847

  Price, Catherine C ^a   Tanner, Jared J ^a   Schmalfuss, Ilona M ^b,c   Brumback, Babette ^a   Heilman, Kenneth M ^a   Libon, David J ^d  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c College of Medicine ^*  (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Caudate nucleus; executive function; hippocampus; lacune; learning; leukoaraiosis; memory; Philadelphia (repeatable) Verbal Learning Test; ventricles; white matter abnormalities

Indexed keywords

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN SIZE; BRAIN VENTRICLE; CAUDATE NUCLEUS; EXECUTIVE FUNCTION; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; LANGUAGE DISABILITY; LANGUAGE TEST; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MEMORY TEST; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHENOTYPE; WHITE MATTER; ALGORITHM; BRAIN; CLUSTER ANALYSIS; DEMENTIA, VASCULAR; DIFFERENTIAL DIAGNOSIS; MENTAL HEALTH; MULTIVARIATE ANALYSIS; ORGAN SIZE; PATHOLOGY; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; BRAIN; CLUSTER ANALYSIS; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; WHITE MATTER;

EID: 84943802916     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150407     Document Type: Article

References (74)

1. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL (2014) Advancing research diagnostic criteria for Alzheimer's disease: The IWG-2 criteria. Lancet Neurol 13, 614-629.
2. Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA (2009) The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis 18, 691-701.
3. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA(2009) The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 66, 200-208.
4. Wharton SB, Brayne C, Savva GM, Matthews FE, Forster G, Simpson J, Lace G, Ince PG, Medical Research Council Cognitive Function and Aging Study (2011) Epidemiological neuropathology: The MRC Cognitive Function and Aging Study experience. J Alzheimers Dis 25, 359-372.
5. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study. Lancet Neurol 10, 785-796.
6. NohY, Jeon S, Lee JM, SeoSW, KimGH, Cho H, Ye BS, Yoon CW, Kim HJ, Chin J, Park KH, Heilman KM, Na DL (2014) Anatomical heterogeneity of Alzheimer disease: Based on cortical thickness on MRIs. Neurology 83, 1936-1944.
7. Libon DJ, Drabick DA, Giovannetti T, Price CC, Bondi MW, Eppig J, Devlin K, Nieves C, Lamar M, Delano-Wood L, Nation DA, Brennan L, Au R, Swenson R (2014) Neuropsychological syndromes associated with Alzheimer's/vascular dementia: A latent class analysis. J Alzheimers Dis 42, 999-1014.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
9. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42, 473-480.
10. Hachinski VC, Potter P, Merskey H (1986) Leuko-araiosis: An ancient term for a new problem. Can J Neurol Sci 13, 533-534.
11. Hachinski VC, Potter P, Merskey H (1987) Leuko-araiosis. Arch Neurol 44, 21-23.
12. Victoroff J, Mack WJ, Lyness SA, Chui HC (1995) Multicenter clinicopathological correlation in dementia. Am J Psychiatry 152, 1476-1484.
13. Gurol ME, Viswanathan A, Gidicsin C, Hedden T, Martinez-Ramirez S, Dumas A, Vashkevich A, Ayres AM, Auriel E, van Etten E, Becker A, Carmasin J, Schwab K, Rosand J, Johnson KA, Greenberg SM (2013) Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study. Ann Neurol 73, 529-536.
14. Posluszny DM, Edwards RP, Dew MA, Baum A (2011) Perceived threat and PTSD symptoms in women undergoing surgery for gynecologic cancer or benign conditions. Psychooncology 20, 783-787.
15. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32, 632-637.
16. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1), S208-219.
17. Shattuck DW, Leahy RM (2000) Brainsuite: An automated cortical surface identification tool. In MICCAI 2000, LNCS 1935, Delp SL, DiGioia AM, Jaramaz B, eds. Springer-Verlab Berlin Heidelberg, pp. 50-61.
18. Bigler ED, TateDF(2001) Brain volume, intracranial volume, and dementia. Invest Radiol 36, 539-546.
19. Bigler ED, Neeley ES, Miller MJ, Tate DF, Rice SA, Cleavinger H, Wolfson L, Tschanz J, Welsh-BohmerK(2004) Cerebral volume loss, cognitive deficit and neuropsychological performance: Comparative measures of brain atrophy: I. Dementia. J Int Neuropsychol Soc 10, 442-452.
20. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G (2006) User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage 31, 1116-1128.
21. Duvernoy HM (2005) The human hippocampus: Functional anatomy, vascularization, and serial sections with MRI, Springer, Berlin; New York.
22. Schwab NA, Tanner JJ, Nguyen PT, Schmalfuss IM, Bowers D, Okun M, Price CC (2014) Proof of principle: Transformation approach alters caudate nucleus volume and structure-function associations. Brain Imaging Behav. doi: 10. 1007/s11682-014-9332-x
23. Price CC, Mitchell SM, Brumback B, Tanner JJ, Schmalfuss I, Lamar M, Giovannetti T, Heilman K, Libon DJ (2012) MRI-leukoaraiosis thresholds and the phenotypic expression of dementia. Neurology 79, 734-740.
24. Abramaoff M, Magelhaes P, Ram S (2004) Image processing with ImageJ. Biophotonics Int 11, 36-42.
25. Zijdenbos AP, Dawant BM (1994) Brain segmentation and white matter lesion detection in MR images. Crit Rev Biomed Eng 22, 401-465.
26. Schmahmann JD, Pandya DN (2006) Fiber pathways of the brain, Oxford University Press, Oxford; New York.
27. Schmahmann JD, Pandya DN (2008) Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems. Cortex 44, 1037-1066.
28. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17, 479-489.
29. Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5, 143-156.
30. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17, 825-841.
31. Liem MK, van der Grond J, Haan J, van den Boom R, Ferrari MD, Knaap YM, Breuning MH, van Buchem MA, Middelkoop HA, Lesnik Oberstein SA (2007) Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL. Stroke 38, 923-928.
32. Eppig J, Wambach D, Nieves C, Price CC, Lamar M, Delano-Wood L, Giovannetti T, Bettcher BM, Penney DL, Swenson R, Lippa C, Kabasakalian A, Bondi MW, Libon DJ (2012) Dysexecutive functioning in mild cognitive impairment: Derailment in temporal gradients. J Int Neuropsychol Soc 18, 20-28.
33. Lamar M, Price CC, Davis KL, Kaplan E, Libon DJ (2002) Capacity to maintain mental set in dementia. Neuropsychologia 40, 435-445.
34. Tombaugh TN, Kozak J, Rees L (1999) Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 14, 167-177.
35. Kaplan E, Goodglass H, Weintrab S (1983) The Boston Naming Test, Lea & Febiger, Philadelphia.
36. Carew TG, Lamar M, Cloud BS, Grossman M, Libon DJ (1997) Impairment in category fluency in ischemic vascular dementia. Neuropsychology 11, 400-412.
37. Price CC, Garrett KD, Jefferson AL, Cosentino S, Tanner JJ, Penney DL, Swenson R, Giovannetti T, Bettcher BM, Libon DJ (2009) Leukoaraiosis severity and list-learning in dementia. Clin Neuropsychol 23, 944-961.
38. Libon DJ, Bondi MW, Price CC, Lamar M, Eppig J, Wambach DM, Nieves C, Delano-Wood L, Giovannetti T, Lippa C, Kabasakalian A, Cosentino S, Swenson R, Penney DL (2011) Verbal serial list learning in mild cognitive impairment: A profile analysis of interference, forgetting, and errors. J Int Neuropsychol Soc 17, 905-914.
39. Delis DC, Kramer JH, Kaplan E, Ober BA (1987) The California Verbal Learning Test, Psychology Corporation, New York.
40. Cohen J (1969) Statistical power analyses for the behavioral sciences, Academic Press, New York.
41. Davidson JE, Irizarry MC, Bray BC, Wetten S, Galwey N, Gibson R, Borrie M, Delisle R, Feldman HH, Hsiung GY, Fornazzari L, Gauthier S, Guzman D, Loy-English I, Keren R, Kertesz A, George-Hyslop PS, Wherrett J, Monsch AU (2010) An exploration of cognitive subgroups in Alzheimer's disease. J Int Neuropsychol Soc 16, 233-243.
42. Fisher NJ, Rourke BP, Bieliauskas L, Giordani B, Berent S, Foster NL (1996) Neuropsychological subgroups of patients with Alzheimer's disease. J Clin Exp Neuropsychol 18, 349-370.
43. Fisher NJ, Rourke BP, Bieliauskas LA (1999) Neuropsychological subgroups of patients with Alzheimer's disease: An examination of the first 10 years of CERAD data. J Clin Exp Neuropsychol 21, 488-518.
44. Kohler S, Hamel R, Sistermans N, Koene T, Pijnenburg YA, van der Flier WM, Scheltens P, Visser PJ, Aalten P, Verhey FR, Ramakers I (2013) Progression to dementia in memory clinic patients without dementia: A latent profile analysis. Neurology 81, 1342-1349.
45. Stopford CL, Snowden JS, Thompson JC, Neary D (2007) Distinct memory profiles in Alzheimer's disease. Cortex 43, 846-857.
46. Stopford CL, Snowden JS, Thompson JC, Neary D (2008) Variability in cognitive presentation of Alzheimer's disease. Cortex 44, 185-195.
47. Beh SC, Muthusamy B, Calabresi P, Hart J, Zee D, Patel V, Frohman E (2015) Hiding in plain sight: A closer look at posterior cortical atrophy. Pract Neurol 15, 5-13.
48. Crutch SJ, Schott JM, Rabinovici GD, Boeve BF, Cappa SF, Dickerson BC, Dubois B, Graff-Radford NR, Krolak-Salmon P, Lehmann M, Mendez MF, Pijnenburg Y, Ryan NS, Scheltens P, Shakespeare T, Tang-Wai DF, van der Flier WM, Bain L, Carrillo MC, Fox NC (2013) Shining a light on posterior cortical atrophy. Alzheimers Dement 9, 463-465.
49. Meguro K, Tanaka N, Nakatsuka M, Nakamura K, Satoh M (2012) Vascular lesions in mixed dementia, vascular dementia, and Alzheimer disease with cerebrovascular disease: The Kurihara Project. J Neurol Sci 322, 157-160.
50. LangaKM, LevineDA(2014) The diagnosis and management of mild cognitive impairment: A clinical review. JAMA 312, 2551-2561.
51. Moller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, van der FlierW(2013) Different patterns of gray matter atrophy in early-and late-onset Alzheimer's disease. Neurobiol Aging 34, 2014-2022.
52. Smits LL, Tijms BM, Benedictus MR, Koedam EL, Koene T, Reuling IE, Barkhof F, Scheltens P, Pijnenburg YA, Wattjes MP, van der Flier WM (2014) Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease. Alzheimers Dement 10, S299-S305.
53. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
54. Halliday G, Lees A, Stern M (2011) Milestones in Parkinson's disease-clinical and pathologic features. Mov Disord 26, 1015-1021.
55. Schmahmann JD, Smith EE, Eichler FS, Filley CM (2008) Cerebral white matter: Neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci 1142, 266-309.
56. Seo SW, Lee JM, Im K, Park JS, Kim SH, Kim ST, Ahn HJ, Chin J, Cheong HK, Weiner MW, Na DL (2011) Cortical thinning related to periventricular and deep white matter hyperintensities. Neurobiol Aging 33, 1156-1167.
57. Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, Nelson J, Hardman J, Masaki K, Vogt MR, Launer L, White LR (2005) AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 57, 98-103.
58. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817.
59. ThomasDA, Libon DJ, Ledakis GE (2005) Treating dementia patients with vascular lesions with donepezil: A preliminary analysis. Appl Neuropsychol 12, 12-18.
60. Dhanjal NS, Wise RJS (2014) Frontoparietal cognitive control of verbal memory recall in Alzheimer's disease. Ann Neurol 76, 241-251.
61. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1, 103-116.
62. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
63. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 59, 23-30.
64. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association/american stroke association. Stroke 42, 2672-2713.
65. Kim GH, Lee JH, Seo SW, Kim JH, Seong JK, Ye BS, Cho H, Noh Y, Kim HJ, Yoon CW, Oh SJ, Kim JS, Choe YS, Lee KH, Kim ST, Hwang JW, Jeong JH, Na DL (2015) Hippocampal volume and shape in pure subcortical vascular dementia. Neurobiol Aging 36, 485-491.
66. Villeneuve S, Jagust WJ (2015) Imaging vascular disease and amyloid in the aging brain: Implications for treatment. J Prev Alzheimers Dis 2, 64-70.
67. Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12, 723-738.
68. Canobbio I, Abubaker AA, Visconte C, Torti M, PulaG(2015) Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease. Front Cell Neurosci 9, 65.
69. Kalaria RN (2012) Risk factors and neurodegenerative mechanisms in stroke related dementia. Panminerva Med 54, 139-148.
70. Honjo K, Black SE, Verhoeff NP (2012) Alzheimer's disease, cerebrovascular disease, and the beta-amyloid cascade. Can J Neurol Sci 39, 712-728.
71. Sutcliffe JG, Hedlund PB, Thomas EA, Bloom FE, Hilbush BS (2011) Peripheral reduction of beta-amyloid is sufficient to reduce brain beta-amyloid: Implications for Alzheimer's disease. J Neurosci Res 89, 808-814.
72. Duara R, LoewensteinDA, Greig MT, Potter E, BarkerW, Raj A, Schinka J, Borenstein A, Schoenberg M, Wu Y, Banko J, PotterH(2011) Pre-MCI and MCI: Neuropsychological, clinical, and imaging features and progression rates. Am J Geriatr Psychiatry 19, 951-960.
73. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, WagsterMV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
74. Price CC, Tanner JJ, Schmalfuss I, Garvan CW, Gearen P, Dickey D, Heilman K, McDonagh DL, Libon DJ, Leonard C, Bowers D, Monk TG (2014) A pilot study evaluating presurgery neuroanatomical biomarkers for postoperative cognitive decline after total knee arthroplasty in older adults. Anesthesiology 120, 601-613.